View source for LY-379,268

== LY-379,268 ==

'''LY-379,268''' (pronounced L-Y-Three-Seven-Nine-Two-Six-Eight) is a [[pharmacological]] agent that is used in scientific research. It is a [[selective]] [[agonist]] for the [[metabotropic glutamate receptor]] group II subtypes [[mGluR2]] and [[mGluR3]].

=== Etymology ===

The name '''LY-379,268''' is derived from the naming convention used by the pharmaceutical company [[Eli Lilly and Company]], where "LY" stands for Lilly and the number is a unique identifier for the compound. The exact etymology of the number 379,268 is not publicly disclosed.

=== Pharmacology ===

'''LY-379,268''' is a potent and selective agonist for the group II metabotropic glutamate receptors (mGluR2 and mGluR3). It has been used in scientific research to investigate the role of these receptors in various [[neurological]] and [[psychiatric]] conditions, including [[schizophrenia]], [[anxiety disorders]], and [[drug addiction]].

=== Related Terms ===

* [[Agonist]]: A substance that initiates a physiological response when combined with a receptor.
* [[Metabotropic glutamate receptor]]: A type of glutamate receptor that is active through a metabolic process.
* [[mGluR2]] and [[mGluR3]]: Subtypes of the metabotropic glutamate receptor.
* [[Eli Lilly and Company]]: The pharmaceutical company that developed LY-379,268.
* [[Neurological]]: Pertaining to the nervous system.
* [[Psychiatric]]: Pertaining to mental health or the treatment of mental illness.

[[Category:Pharmacology]]
[[Category:Neuroscience]]
[[Category:Psychiatry]]

{{dictionary-stub}}